Opus Genetics, Inc. (IRD) — Cash Flow Reinvestment Rate
Opus Genetics, Inc. (IRD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $4.55 Million. Check Opus Genetics, Inc. (IRD) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Opus Genetics, Inc. Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Opus Genetics, Inc. across 1 annual periods. Explore Opus Genetics, Inc. (IRD) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Opus Genetics, Inc. (2022–2022)
Year-by-year capital reinvestment analysis for Opus Genetics, Inc.. For live market cap and broader valuation context, see Opus Genetics, Inc. market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $14.31 Million | $0.00 | — |